pazopanib zentiva 200 mg apvalkotās tabletes
zentiva, k.s., czech republic - pazopanibs - apvalkotā tablete - 200 mg
pazopanib zentiva 400 mg apvalkotās tabletes
zentiva, k.s., czech republic - pazopanibs - apvalkotā tablete - 400 mg
pazopanib teva 200 mg apvalkotās tabletes
teva b.v., netherlands - pazopanibs - apvalkotā tablete - 200 mg
amvuttra
alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - other nervous system drugs - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.
tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastiski līdzekļi - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.
pazopanib accord 200 mg apvalkotās tabletes
accord healthcare b.v., netherlands - pazopanibs - apvalkotā tablete - 200 mg
pazopanib accord 400 mg apvalkotās tabletes
accord healthcare b.v., netherlands - pazopanibs - apvalkotā tablete - 400 mg
pazopanib viatris 200 mg apvalkotās tabletes
viatris limited, ireland - pazopanibs - apvalkotā tablete - 200 mg
pazopanib viatris 400 mg apvalkotās tabletes
viatris limited, ireland - pazopanibs - apvalkotā tablete - 400 mg